Figure S2 from T cell-intrinsic immunomodulatory effects of TAK-981 (subasumstat), a SUMO-activating enzyme inhibitor, in chronic lymphocytic leukemia Article Swipe

View

Vi Lam , Carly Roleder , Tingting Liu , Nur Bruss , Scott Best , Xiaoguang Wang , Tycel Phillips , Geoffrey Shouse , Allison Berger , Lapo Alinari , Lili Wang , Tanya Siddiqi , Nathan D. Pennock , Alexey V. Danilov ·

YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1158/1535-7163.27036331.v1

Figure S2 shows Magnetically enriched CD3+ T cells were activated with 0.5 µg/mL αCD3/28 in the presence of TAK-981 or vehicle control for up to 96 h

Related Topics

Concepts

Chronic lymphocytic leukemia Leukemia Enzyme Cancer research Chemistry Medicine Immunology Biochemistry

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/1535-7163.27036331.v1
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4402798649

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4402798649

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/1535-7163.27036331.v1

Digital Object Identifier
Title: Figure S2 from T cell-intrinsic immunomodulatory effects of TAK-981 (subasumstat), a SUMO-activating enzyme inhibitor, in chronic lymphocytic leukemia

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2024

Year of publication
Publication date: 2024-09-16

Full publication date if available
Authors: Vi Lam, Carly Roleder, Tingting Liu, Nur Bruss, Scott Best, Xiaoguang Wang, Tycel Phillips, Geoffrey Shouse, Allison Berger, Lapo Alinari, Lili Wang, Tanya Siddiqi, Nathan D. Pennock, Alexey V. Danilov

List of authors in order
Landing page: https://doi.org/10.1158/1535-7163.27036331.v1

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://doi.org/10.1158/1535-7163.27036331.v1

Direct OA link when available
Concepts: Chronic lymphocytic leukemia, Leukemia, Enzyme, Cancer research, Chemistry, Medicine, Immunology, Biochemistry

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4402798649
doi	https://doi.org/10.1158/1535-7163.27036331.v1
ids.doi	https://doi.org/10.1158/1535-7163.27036331.v1
ids.openalex	https://openalex.org/W4402798649
fwci	0.0
type	preprint
title	Figure S2 from T cell-intrinsic immunomodulatory effects of TAK-981 (subasumstat), a SUMO-activating enzyme inhibitor, in chronic lymphocytic leukemia
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11041
topics[0].field.id	https://openalex.org/fields/13
topics[0].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[0].score	0.9929999709129333
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/1312
topics[0].subfield.display_name	Molecular Biology
topics[0].display_name	Ubiquitin and proteasome pathways
topics[1].id	https://openalex.org/T13430
topics[1].field.id	https://openalex.org/fields/27
topics[1].field.display_name	Medicine
topics[1].score	0.9413999915122986
topics[1].domain.id	https://openalex.org/domains/4
topics[1].domain.display_name	Health Sciences
topics[1].subfield.id	https://openalex.org/subfields/2705
topics[1].subfield.display_name	Cardiology and Cardiovascular Medicine
topics[1].display_name	Lipid metabolism and disorders
topics[2].id	https://openalex.org/T11157
topics[2].field.id	https://openalex.org/fields/27
topics[2].field.display_name	Medicine
topics[2].score	0.9276999831199646
topics[2].domain.id	https://openalex.org/domains/4
topics[2].domain.display_name	Health Sciences
topics[2].subfield.id	https://openalex.org/subfields/2716
topics[2].subfield.display_name	Genetics
topics[2].display_name	Chronic Lymphocytic Leukemia Research
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C2777938653
concepts[0].level	3
concepts[0].score	0.7834520936012268
concepts[0].wikidata	https://www.wikidata.org/wiki/Q1088156
concepts[0].display_name	Chronic lymphocytic leukemia
concepts[1].id	https://openalex.org/C2778461978
concepts[1].level	2
concepts[1].score	0.5773003697395325
concepts[1].wikidata	https://www.wikidata.org/wiki/Q29496
concepts[1].display_name	Leukemia
concepts[2].id	https://openalex.org/C181199279
concepts[2].level	2
concepts[2].score	0.48565351963043213
concepts[2].wikidata	https://www.wikidata.org/wiki/Q8047
concepts[2].display_name	Enzyme
concepts[3].id	https://openalex.org/C502942594
concepts[3].level	1
concepts[3].score	0.4271731376647949
concepts[3].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[3].display_name	Cancer research
concepts[4].id	https://openalex.org/C185592680
concepts[4].level	0
concepts[4].score	0.36787664890289307
concepts[4].wikidata	https://www.wikidata.org/wiki/Q2329
concepts[4].display_name	Chemistry
concepts[5].id	https://openalex.org/C71924100
concepts[5].level	0
concepts[5].score	0.3517478108406067
concepts[5].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[5].display_name	Medicine
concepts[6].id	https://openalex.org/C203014093
concepts[6].level	1
concepts[6].score	0.2692490518093109
concepts[6].wikidata	https://www.wikidata.org/wiki/Q101929
concepts[6].display_name	Immunology
concepts[7].id	https://openalex.org/C55493867
concepts[7].level	1
concepts[7].score	0.14416518807411194
concepts[7].wikidata	https://www.wikidata.org/wiki/Q7094
concepts[7].display_name	Biochemistry
keywords[0].id	https://openalex.org/keywords/chronic-lymphocytic-leukemia
keywords[0].score	0.7834520936012268
keywords[0].display_name	Chronic lymphocytic leukemia
keywords[1].id	https://openalex.org/keywords/leukemia
keywords[1].score	0.5773003697395325
keywords[1].display_name	Leukemia
keywords[2].id	https://openalex.org/keywords/enzyme
keywords[2].score	0.48565351963043213
keywords[2].display_name	Enzyme
keywords[3].id	https://openalex.org/keywords/cancer-research
keywords[3].score	0.4271731376647949
keywords[3].display_name	Cancer research
keywords[4].id	https://openalex.org/keywords/chemistry
keywords[4].score	0.36787664890289307
keywords[4].display_name	Chemistry
keywords[5].id	https://openalex.org/keywords/medicine
keywords[5].score	0.3517478108406067
keywords[5].display_name	Medicine
keywords[6].id	https://openalex.org/keywords/immunology
keywords[6].score	0.2692490518093109
keywords[6].display_name	Immunology
keywords[7].id	https://openalex.org/keywords/biochemistry
keywords[7].score	0.14416518807411194
keywords[7].display_name	Biochemistry
language	en
locations[0].id	doi:10.1158/1535-7163.27036331.v1
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/1535-7163.27036331.v1
locations[1].id	pmh:oai:figshare.com:article/27036331
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url	https://figshare.com/articles/journal_contribution/Figure_S2_from_T_cell-intrinsic_immunomodulatory_effects_of_TAK-981_subasumstat_a_SUMO-activating_enzyme_inhibitor_in_chronic_lymphocytic_leukemia/27036331
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5021469964
authorships[0].author.orcid	https://orcid.org/0000-0003-4578-3531
authorships[0].author.display_name	Vi Lam
authorships[0].author_position	first
authorships[0].raw_author_name	Vi Lam
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5030727533
authorships[1].author.orcid	https://orcid.org/0009-0001-9844-0367
authorships[1].author.display_name	Carly Roleder
authorships[1].author_position	middle
authorships[1].raw_author_name	Carly Roleder
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5004580825
authorships[2].author.orcid	https://orcid.org/0000-0002-1695-8649
authorships[2].author.display_name	Tingting Liu
authorships[2].author_position	middle
authorships[2].raw_author_name	Tingting Liu
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5004071926
authorships[3].author.orcid	https://orcid.org/0009-0009-9995-4982
authorships[3].author.display_name	Nur Bruss
authorships[3].author_position	middle
authorships[3].raw_author_name	Nur Bruss
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5031308530
authorships[4].author.orcid	https://orcid.org/0000-0002-0461-7919
authorships[4].author.display_name	Scott Best
authorships[4].author_position	middle
authorships[4].raw_author_name	Scott Best
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5102734922
authorships[5].author.orcid	https://orcid.org/0000-0002-8185-0319
authorships[5].author.display_name	Xiaoguang Wang
authorships[5].author_position	middle
authorships[5].raw_author_name	Xiaoguang Wang
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5062534813
authorships[6].author.orcid	https://orcid.org/0000-0003-2143-9672
authorships[6].author.display_name	Tycel Phillips
authorships[6].author_position	middle
authorships[6].raw_author_name	Tycel Phillips
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5013241767
authorships[7].author.orcid	https://orcid.org/0000-0002-7917-5713
authorships[7].author.display_name	Geoffrey Shouse
authorships[7].author_position	middle
authorships[7].raw_author_name	Geoffrey Shouse
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5010026747
authorships[8].author.orcid	https://orcid.org/0000-0003-1217-2005
authorships[8].author.display_name	Allison Berger
authorships[8].author_position	middle
authorships[8].raw_author_name	Allison J. Berger
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5054730003
authorships[9].author.orcid	https://orcid.org/0000-0002-8870-4162
authorships[9].author.display_name	Lapo Alinari
authorships[9].author_position	middle
authorships[9].raw_author_name	Lapo Alinari
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5058018350
authorships[10].author.orcid
authorships[10].author.display_name	Lili Wang
authorships[10].author_position	middle
authorships[10].raw_author_name	Lili Wang
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5005565037
authorships[11].author.orcid	https://orcid.org/0000-0001-5292-8298
authorships[11].author.display_name	Tanya Siddiqi
authorships[11].author_position	middle
authorships[11].raw_author_name	Tanya Siddiqi
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5038644402
authorships[12].author.orcid	https://orcid.org/0000-0001-5374-7843
authorships[12].author.display_name	Nathan D. Pennock
authorships[12].author_position	middle
authorships[12].raw_author_name	Nathan D. Pennock
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5067633124
authorships[13].author.orcid	https://orcid.org/0000-0003-4461-0970
authorships[13].author.display_name	Alexey V. Danilov
authorships[13].author_position	last
authorships[13].raw_author_name	Alexey V. Danilov
authorships[13].is_corresponding	False
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://doi.org/10.1158/1535-7163.27036331.v1
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Figure S2 from T cell-intrinsic immunomodulatory effects of TAK-981 (subasumstat), a SUMO-activating enzyme inhibitor, in chronic lymphocytic leukemia
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T11041
primary_topic.field.id	https://openalex.org/fields/13
primary_topic.field.display_name	Biochemistry, Genetics and Molecular Biology
primary_topic.score	0.9929999709129333
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1312
primary_topic.subfield.display_name	Molecular Biology
primary_topic.display_name	Ubiquitin and proteasome pathways
related_works	https://openalex.org/W4387497383, https://openalex.org/W2948807893, https://openalex.org/W2778153218, https://openalex.org/W2748952813, https://openalex.org/W1531601525, https://openalex.org/W4391375266, https://openalex.org/W2078814861, https://openalex.org/W2527526854, https://openalex.org/W579273576, https://openalex.org/W2418031697
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/1535-7163.27036331.v1
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/1535-7163.27036331.v1
primary_location.id	doi:10.1158/1535-7163.27036331.v1
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/1535-7163.27036331.v1
publication_date	2024-09-16
publication_year	2024
referenced_works_count	0
abstract_inverted_index.T	6
abstract_inverted_index.96	25
abstract_inverted_index.S2	1
abstract_inverted_index.in	14
abstract_inverted_index.of	17
abstract_inverted_index.or	19
abstract_inverted_index.to	24
abstract_inverted_index.up	23
abstract_inverted_index.0.5	11
abstract_inverted_index.for	22
abstract_inverted_index.the	15
abstract_inverted_index.CD3+	5
abstract_inverted_index.were	8
abstract_inverted_index.with	10
abstract_inverted_index.cells	7
abstract_inverted_index.shows	2
abstract_inverted_index.µg/mL	12
abstract_inverted_index.TAK-981	18
abstract_inverted_index.control	21
abstract_inverted_index.vehicle	20
abstract_inverted_index.enriched	4
abstract_inverted_index.presence	16
abstract_inverted_index.αCD3/28	13
abstract_inverted_index.activated	9
abstract_inverted_index.h</p>	26
abstract_inverted_index.Magnetically	3
abstract_inverted_index.<p>Figure	0
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	14
citation_normalized_percentile.value	0.18284364
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False